Efficacy and Safety of LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis Vulgaris
Phase of Trial: Phase III
Latest Information Update: 05 May 2017
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Plaque psoriasis
- Focus Registrational; Therapeutic Use
- Sponsors LEO Pharma
- 14 Sep 2016 Status changed from recruiting to completed.
- 13 Feb 2016 New trial record
- 11 Feb 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.